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Abstract
Background: Underuse and overuse of diagnostic tests have important implications for health outcomes and
costs. Decision support technology purports to optimize the use of diagnostic tests in clinical practice. The
objective of this review was to assess whether computerized clinical decision support systems (CCDSSs) are
effective at improving ordering of tests for diagnosis, monitoring of disease, or monitoring of treatment. The
outcome of interest was effect on the diagnostic test-ordering behavior of practitioners.
Methods: We conducted a decision-maker-researcher partnership systematic review. We searched MEDLINE,
EMBASE, Ovid’s EBM Reviews database, Inspec, and reference lists for eligible articles published up to January 2010.
We included randomized controlled trials comparing the use of CCDSSs to usual practice or non-CCDSS controls in
clinical care settings. Trials were eligible if at least one component of the CCDSS gave suggestions for ordering or
performing a diagnostic procedure. We considered studies ‘positive’ if they showed a statistically significant
improvement in at least 50% of test ordering outcomes.
Results: Thirty-five studies were identified, with significantly higher methodological quality in those published after
the year 2000 (p = 0.002). Thirty-three trials reported evaluable data on diagnostic test ordering, and 55% (18/33) of
CCDSSs improved testing behavior overall, including 83% (5/6) for diagnosis, 63% (5/8) for treatment monitoring,
35% (6/17) for disease monitoring, and 100% (3/3) for other purposes. Four of the systems explicitly attempted to
reduce test ordering rates and all succeeded. Factors of particular interest to decision makers include costs, user
satisfaction, and impact on workflow but were rarely investigated or reported.
Conclusions: Some CCDSSs can modify practitioner test-ordering behavior. To better inform development and
implementation efforts, studies should describe in more detail potentially important factors such as system design,
user interface, local context, implementation strategy, and evaluate impact on user satisfaction and workflow, costs,
and unintended consequences.
Background
Much of medical care hinges on performing the right
t e s t ,o nt h er i g h tp a t i e n t ,a tt h er i g h tt i m e .A p a r tf r o m
their financial cost, diagnostic tests have downstream
implications on care and, ultimately, patient outcomes.
Yet, studies suggest wide variation in diagnostic test
ordering behavior for seemingly similar patients [1-4].
This variation may be due to overuse or underuse of
tests and may reflect inaccurate interpretation of results,
rapid advances in diagnostic technology, and challenges
in estimating tests’ performance characteristics [5-10].
Thus, developing effective strategies to optimize health-
care practitioners’ diagnostic test ordering behavior has
become a major concern [11].
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educational messages, reminders, and computerized
clinical decision support systems (CCDSSs) [2,12-14].
For example, Thomas et al. [15] programmed a labora-
tory information system to automatically produce
reminder messages that discourage future inappropriate
use for each of nine diagnostic tests. A systematic
review of strategies to change test-ordering behavior
c o n c l u d e dt h a tm o s ti n t e r v e n t i o n sa s s e s s e dw e r ee f f e c -
tive [2]. However, this review was limited by the low
quality of primary studies. More recently, Shojania et al.
[16] quantified the magnitude of improvements in pro-
cesses of care from computer reminders delivered to
physicians for any clinical purpose. Pooling data across
randomized trials, they found a modest 3.8% median
improvement (interquartile range [IQR], 15.9%) in
adherence to test ordering reminders.
CCDSSs match characteristics of individual patients to
ac o m p u t e r i z e dk n o w l e d g ebase and provide patient-
specific recommendations. The Health Information
Research Unit (HIRU) at McMaster University pre-
viously conducted a systematic review assessing the
effects of CCDSSs on practitioner performance and
patient outcomes in 1994 [17], updated it in 1998 [18],
and most recently in 2005 [19]. However, these reviews
have not focused specifically on the use of diagnostic
tests.
In this current update, we had the opportunity to
partner with local hospital administration, clinical staff,
and representatives of our regional health authority, in
anticipation of major institutional investments in health
information technology. Many new studies have been
published in this field since our previous work in 2005
[19] allowing us to focus on randomized controlled
trials (RCTs), with their lessened risk of bias. To better
address the information needs of our decision-making
partners, we focused on six separate topics for review:
diagnostic test ordering, primary preventive care, drug
prescribing, acute medical care, chronic disease manage-
ment, and therapeutic drug monitoring and dosing. In
this paper, we determine if CCDSSs improve practi-
tioners’ diagnostic test ordering behavior.
Methods
We previously published detailed methods for conduct-
ing this systematic review available at http://www.imple-
mentationscience.com/content/5/1/12[20]. These
methods are briefly summarized here, along with details
specific to this review of CCDSSs for diagnostic test
ordering.
Research question
Do CCDSSs improve practitioners’ diagnostic test order-
ing behavior?
Partnering with decision makers
The research team engaged key decision makers early in
the project to guide its design and endorse its funding
application. Direction for the overall review was pro-
vided by senior administrators at Hamilton Health
Sciences (one of Canada’s largest teaching hospitals) and
our regional health authority. JY (Department of Medi-
cine) and DK (Chair, Department of Radiology) provided
specific guidance for the area of diagnostic test ordering
by selecting from each study the outcomes relevant to
diagnostic testing. HIRU research staff searched for and
selected trials for inclusion, as well as extracted and
synthesised pertinent data. All partners worked together
through the review process to facilitate knowledge trans-
lation, that is, to define whether and how to transfer
findings into clinical practice.
Search strategy
We previously published the details of our search strat-
egy [20]. Briefly, we examined citations retrieved from
MEDLINE, EMBASE, Ovid’s Evidence-Based Medicine
Reviews, and Inspec bibliographic databases up to 6 Jan-
uary 2010, and hand-searched the reference lists of
included articles and relevant systematic reviews.
Study selection
In pairs, our reviewers independently evaluated each
study’s eligibility for inclusion, and a third observer
resolved disagreements. We first included all RCTs that
assessed a CCDSS’s effect on healthcare processes in
which the system was used by healthcare professionals
and provided patient-specific assessments or recommen-
dations. We then selected trials of systems that gave
direct recommendations to order or not to order a diag-
nostic test, or presented testing options, and measured
impact on diagnostic processes. Trials of systems that
simply gave advice for interpreting test results were
excluded (such as Poels et al. [21]), as were trials of
diagnostic systems that only reasoned through patient
characteristics to suggest a diagnosis without making
test recommendations (such as Bogusevicius et al. [22]).
Systems that provided only information, such as cost of
testing [23] or past test results [24] without actionable
recommendations or options were also excluded.
Data extraction
Pairs of reviewers independently extracted data from all
eligible trials, including a wide range of system design
and implementation characteristics, study methods, set-
ting, funding sources, patient/provider characteristics,
and effects on care process and clinical outcomes,
adverse effects, effects on workflow, costs, and practi-
tioner satisfaction. Disagreements were resolved by a
third reviewer or by consensus. We attempted to
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extracted data and to provide missing data, receiving a
response from 69% (24/35).
Assessment of study quality
We assessed the methodological quality of eligible trials
with a 10-point scale consisting of five potential sources
of bias, including concealment of allocation, appropriate
unit of allocation, appropriate adjustment for baseline
differences, appropriate blinding of assessment, and ade-
quate follow-up [20]. For each source of bias, a score of
0 indicated the highest potential for bias, whereas a
score of 2 indicated the lowest, generating a range of
scores from 0 (lowest study quality) to 10 (highest study
quality). We used a 2-tailed Mann-Whitney U test to
assess whether the quality of trials has improved with
time, comparing methodologic scores between trials
published before the year 2000 and those published
later.
Assessment of CCDSS intervention effects
In determining effectiveness, we focused exclusively on
diagnostic testing measures and defined these broadly to
include performing physical examinations (e.g., eye and
foot exams), blood pressure measurements, as well as
ordering laboratory, imaging, and functional tests.
Patient outcomes were excluded from this study
because, in general, they are most directly affected by
treatment action and could not be attributed solely to
diagnostic testing advice, especially in systems that also
recommended therapy. Impact on patient outcomes and
other process outcomes was assessed in our other cur-
rent reviews on primary preventive care, drug prescrib-
ing, acute medical care, chronic disease management,
and therapeutic drug monitoring and dosing.
Whenever possible, we classified systems as serving at
least one of three purposes: disease monitoring (e.g.,
measuring HbA1c in diabetes), treatment monitoring (e.
g., measuring liver enzymes at time of statin prescrip-
tion), and diagnosis (e.g., laboratory tests to detect
source of fever). We classified trials in each area
depending on whether they gave recommendations for
that purpose and measured the outcome of those
recommendations. Trials of systems for monitoring of
medications with narrow therapeutic indexes, such as
insulin or warfarin, are the focus of a separate report on
CCDSSs for toxic drug monitoring and dosing and are
not discussed here.
We looked for the intended direction of impact: to
increase or to decrease testing. We considered a system
effective if it changed, in the intended direction, a pre-
specified primary outcome measuring use of diagnostic
tests (2-tailed p < 0.05). If multiple pre-specified pri-
mary outcomes were reported, we considered a change
in ≥50% of outcomes to represent effectiveness. We
considered primary those outcomes reported by the
author as ‘primary’ or ‘main,’ or if no such statements
could be found, we considered the outcome used for
sample size calculations to be primary. In the absence
of a relevant primary outcome, we looked for a change
in ≥50% of multiple pre-specified secondary outcomes.
If there were no relevant pre-specified outcomes, sys-
tems that changed ≥50% of reported diagnostic process
outcomes were considered effective. We included stu-
dies with multiple CCDSS arms in the count of ‘posi-
tive’ studies if any of the CCDSS arms showed a benefit
over the control arm. These criteria are more specific
than those used in our previous review [19]; therefore,
some studies included in our earlier review [19] were
re-categorised with respect to their effectiveness in this
review.
Data synthesis and analysis
We summarized data using descriptive measures,
including proportions, medians, and ranges. Denomina-
tors vary in some proportions because not all trials
reported relevant information. We conducted our ana-
lyses using SPSS, version 15.0. Given study-level differ-
ences in participants, clinical settings, disease
conditions, interventions, and outcomes measured, we
did not attempt a meta-analysis.
A sensitivity analysis was conducted to assess the pos-
sibility of biased results in studies with a mismatch
between the unit of allocation (e.g., clinicians) and the
unit of analysis (e.g., individual patients without adjust-
ment for clustering). Success rates comparing studies
with matched and mismatched analyses were compared
using chi-square for comparisons. No differences in
reported success were found for diagnostic process out-
comes (Pearson X
2 = 0.44, p=0.51). Accordingly,
results have been reported without distinction for
mismatch.
Results
Figure 1 shows the flow of included and excluded trials.
Across all clinical indications, we identified 166 RCTs of
CCDSSs and inter-reviewer agreement on study eligibil-
ity was high (unweighted Cohen’s kappa, 0.93; 95% con-
fidence interval [CI], 0.91 to 0.94). In this review, we
included 35 trials described in 45 publications because
they measured the impact on test ordering behavior of
CCDSSs that gave suggestions for ordering or perform-
ing diagnostic tests [15,25-57,57-67]. Thirty-two
included studies contributed outcomes to both this
review and other CCDSS interventions in the series;
four studies [34,37,41,68] to four reviews, 11 studies
[25,32,33,35,36,39,40,42-44,46-49,51,57,61] to three
reviews, and 17 studies [26-31,38,45,50,52-56,
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on diagnostic test ordering process outcomes.
Our assessment of trial quality is summarized in Addi-
tional file 1, Table S1; system characteristics in Addi-
tional file 2, Table S2; study characteristics in Additional
file 3, Table S3; outcome data in Table 1 and Additional
file 4, Table S4; and other CCDSS-related outcomes in
Additional file 5, Table S5.
Study quality
Details of our methodological quality assessment can be
found in Additional file 1, Table S1. Fifty-four percent
of trials concealed group allocation [26,27,30,32-35,
37-40,42-44,50,52-55,60-63,66-68]; 51% allocated clus-
ters (e.g., entire clinics or wards) to minimize contami-
nation between study groups [15,25,28-30,34,
36,38-44,46,50-53,60,62-64,68]; 77% either showed no
differences in baseline characteristics between study
groups or adjusted accordingly [15,26-37,39,40,
45-55,58,59,61-66,68]; 69% of trials achieved ≥90% fol-
low-up for the appropriate unit of analysis
[15,25,28-35,37,39-41,45,50-56,58-61,66,67]; and all but
one used blinding or an objective outcome [45].
Most studies had good methodological quality (med-
ian quality score, 8; ranging from 2 to 10) and 63%
(22/35) [15,25-38,50-55,58-61,65] were published after
our previous search in September 2004. Study quality
improved with time (median score before versus after
year 2000, 7 versus 8, 2-tailed Mann-Whitney U =
44.5; p = 0.002), mainly because early trials did not
conceal allocation and failed to achieve adequate fol-
low-up.
Figure 1 Flow diagram of included and excluded studies for the update 1 January 2004 to 6 January 2010 with specifics for
diagnostic test ordering*. *Details provided in: Haynes RB et al. [20]. Two updating searches were performed, for 2004 to 2009 and to 6
January 2010 and the results of the search process are consolidated here.
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a
Study Methods
score
Indication No. of
centres/
providers/
patients
Diagnostic process (DP) outcomes CCDSS
Effect
b
Disease Monitoring
Gilutz,
2009[25]
7 Reminders for monitoring and treatment of
dyslipidemia in primary care patients with known
coronary artery disease.
112*/600/
7,448
Adequate frequency of lipoprotein monitoring. +
Holbrook,
2009[26,27]
7 Web-based tracking of diabetes monitoring in
adults in primary care.
18/46/511* Semiannual measurement of glycated Hb, LDL-
C, or albuminuria; semiannual foot surveillance;
quarterly measurement of BP or BMI.
+
Maclean,
2009[28,29]
8 Reminders for the management of diabetes in
primary care.
64*/132/
7,412
Testing that was timely for A1C, lipids, serum
creatinine, or urine microalbumin.
+
Peterson,
2008[30]
10 Visit reminders and patient-specific physician
alerts and progress reports for organization of
primary care in patients with type 2 diabetes.
24*/238/
7,101
Improvement in Process of Care Index (annual
BP monitoring; eye and foot exams; renal,
HbA1c, and LDL-C testing).
+
Borbolla,
2007[31]
7 Recommendations for monitoring of BP in
outpatients and primary care patients with
chronic disease.
.../182*/2,315 BP measurement for appropriate patients. +
Lester,
2006[32,33]
8 Recommendations for the management of
dyslipidemia in primary care.
1/14/235* Time to first measured LDL.-C. 0
Cobos
c,
2005[34]
10 Recommendations for hypercholesterolemia
therapy, follow-up visit frequency, and laboratory
test ordering for patients with
hypercholesterolemia in primary care.
42*/.../2,221 Number of patient assessments (lipids). 0
Plaza, 2005
[35]
9 Recommendations for cost-effective
management of asthma in primary care.
.../20*/198 Use of spirometry, conventional blood tests,
total immunoglobulin E, skin allergy tests, or
thorax radiography.
0
Sequist,
2005[36]
6 Reminders for management of diabetes and
coronary artery disease in primary care.
20*/194/
6,243
Receipt of annual cholesterol or dilated eye
exams, or biennial HbA1c exams.
0
Tierney,
2005[37]
9 Recommendations for the management of
asthma and chronic obstructive pulmonary
disease in adults in primary care.
4/266*/706 Adherence to suggestions to obtain pulmonary
function tests.
0
Mitchell
2004[38]
7 Feedback for identification, treatment, and
control of hypertension in elderly patients in
primary care.
52*/.../30,345 Patients with BP not measured. 0
Eccles,
2002[39,40]
10 Recommendations for management of asthma
or angina in adults in primary care.
62*/.../4,506 Adherence to angina guideline
recommendations for recording/advising on BP;
weight; electrocardiograms; thyroid function; Hb,
lipid, cholesterol, blood glucose, and HbA1c
levels; and assessment of lung function.
0
Demakis,
2000[41]
7 Reminders for screening, monitoring, and
counselling in accordance with predefined
standards of care in ambulatory care.
12*/275/
12,989
Compliance with standards of care for coronary
artery disease (lipid levels), hypertension
(weight, exercise, sodium) and diabetes
(glycosylated Hb, urinalysis, eye and foot exams).
+
Hetlevik,
1999
[42-44]
8 Recommendations for diagnosis and
management of hypertension, diabetes mellitus,
and dyslipidemia in primary care.
56*/56/3,273 Hypertensive or diabetic patients without
recorded data for BP, serum cholesterol, or BMI;
and diabetic patients without HbA1c recorded.
0
Lobach,
1997[45]
6 Recommendations for the primary care of
diabetes mellitus for outpatients, including
screening, vaccination, and HbA1c monitoring.
1/58*/497 Compliance with diabetes management
recommendations for foot, ophthalmologic, and
complete physical exams; chronic glycemia
monitoring; urine protein determination; and
cholesterol levels.
0
Mazzuca,
1990[46]
7 Reminders for management of type 2 diabetes
mellitus in outpatients.
4*/114/279 Adherence to recommendations for lab
ordering for glycosylated Hb and fasting blood
sugar; and initiation of home-monitored blood
glucose.
0
Rogers,
1984
[47-49]
4 Recommendations for the management of
hypertension, obesity and renal disease in
outpatients.
1/.../484* Renal function or potassium exams, fundoscopy,
or intravenous pyelograms for hypertensive
patients; and renal function exams, urine
analysis, or urine culture for patients with renal
disease.
0
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a (Continued)
Treatment Monitoring
Lo, 2009
[50]
10 Alerts for ordering laboratory tests when
prescribing new medications in primary care.
22*/366/
2,765
Ordering appropriate baseline laboratory tests. 0
Matheny,
2008[51]
8 Reminders for routine medication laboratory
monitoring in primary care.
20*/303/
1922
Ordering appropriate laboratory tests. 0
Feldstein,
2006a
[52,53]
10 Reminders to order laboratory tests when
prescribing new medications in primary care.
15*/200/961 Completion of all baseline laboratory
monitoring by day 25.
+
Palen, 2006
[54]
9 Reminders for laboratory monitoring based on
medication orders in primary care.
16/207*/
26,586
Compliance with ordering the recommended
laboratory tests.
0
Cobos
c,
2005[34]
10 Recommendations for hypercholesterolemia
therapy, follow-up visit frequency, and laboratory
test ordering for patients with
hypercholesterolemia in primary care.
42*/.../2,221 Number of patient assessments (aspartate or
alanine aminotransferase, or creatine kinase).
+
Raebel,
2005[55]
8 Alerts to order laboratory tests when prescribing
new medications in primary care.
.../.../400,000* Drug dispensing with completed baseline
laboratory monitoring.
+
McDonald,
1980[56]
5 Detection and management of mainly
medication-related problems in outpatients.
1/31*/... Adherence to reminders for recording a finding
or ordering a test.
+
McDonald,
1976[57]
2 Recommendations for laboratory tests to detect
potential medication-related events in adults
attending a diabetes clinic.
1/.../226* Compliance with ordering required tests for
monitoring drug effects.
+
Diagnosis
Sundaram,
2009[58]
7 Reminders for risk assessment and screening for
human immunodeficiency virus in primary care.
5/32*/26,042 Change in human immunodeficiency virus
testing rates.
0
Roukema,
2008[59]
7 Recommendations for the diagnostic
management for children with fever without
apparent source in the emergency department.
1/15/164* Lab tests ordered. +
Downs,
2006[60]
9 Prompts for the investigation and management
of dementia in primary care.
35*/.../450 Detection of dementia and compliance with
diagnostic guidelines.
+
Feldstein,
2006b[61]
8 Reminders for detection and treatment of
osteoporosis in high-risk women in primary care
who experienced a fracture.
15/159/311* Receipt of bone mineral density measurement
or osteoporosis medication.
+
Flottorp,
2002[62,63]
9 Recommendations for management of urinary
tract infections in women or sore throat in
primary care.
142*/.../... Use of laboratory tests for sore throat or urinary
tract infection.
+
McDonald,
1984[64]
6 Reminders for cancer screening (stool occult
blood, mammogram), counselling (weight
reduction), immunization (influenza,
pneumococcal) in addition to >1000 physician
behavior rules for outpatients.
1*/130/
12467
Response to reminders for occult blood, cervical
smear, hematocrit, chest roentgenogram,
tuberculosis skin test, serum K, mammography,
reticulocytes, iron/iron binding, liver enzymes,
and tests for specific conditions.
+
Other
Thomas,
2006[15]
8 Reminders to reduce inappropriate laboratory
test orders in primary care.
85*/370/... Targeted tests requested. +
Javitt, 2005
[65]
6 Recommendations for management of patients
whose care deviates from recommended
practices in primary care.
.../.../39,462* Compliance with diagnostic test ordering
recommendations.
....
Bates, 1999
[66]
8 Reminders to reduce redundant clinical
laboratory tests in hospital inpatients.
1/.../16,586* Tests performed after reminder triggered. +
Overhage,
1997[68]
8 CCDSS identified ‘corollary orders’ (tests or
treatments needed to monitor or ameliorate the
effects of other tests or treatments) to prevent
errors of omission for any of 87 target tests and
treatments in hospital inpatients on a general
medicine ward.
1*/92/2,181 Compliance with corollary orders. ....
Tierney,
1988[67]
6 Provides information to reduce ordering of
unnecessary diagnostic tests in primary care.
1/112/9,496* Probability of abnormal study test. +
Abbreviations: ACE, angiotensin-converting enzyme; BMI, body mass index; BP, blood pressure; CCDSS, computerized clinical decision support system; Hb,
hemoglobin; LDL-C, low-density lipoprotein cholesterol.
*Unit of allocation.
aEllipses (...) indicate item was not assessed or could not be evaluated.
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Systems’ design and implementation characteristics are
presented in Additional file 2, Table S2, but not all trials
reported these details. CCDSSs in 80% of trials (28/35)
gave advice at the time of care [25-27,30,31,34-37,
39-51,54,56-64,66-68]; most were integrated with elec-
tronic medical records (82%; 27/33) [15,26,27,30-34,36,
37,39,40,42-51,54,56-58,60-64,66-68] and some were
integrated with computerized physician order entry
(CPOE) systems (26%; 7/27) [31-33,37,50,54,67,68]; 77%
(24/31) automatically obtained data needed to trigger
recommendations from electronic medical records
[15,26,27,30-34,36,37,39,40,45,46,50,51,54,56-58,60-64,6-
6-68], while others relied on practitioners, existing non-
prescribing staff, or research staff to enter data. In most
trials (61%; 20/33) advice was delivered on a desktop or
laptop computer [15,26,27,31,34,36-41,50,51,54,
58-63,66-68], but other methods included personal digi-
tal assistants, email, or existing staff. Seventy-four per-
cent (26/35) of systems were implemented in primary
care [15,25-40,42-45,50-54,58,60-65,67]; 56% (14/25)
were pilot tested [25,28-33,36,38,42-45,51,
54,62,63,66,67]; and users of 59% (17/29) were trained
[25-29,31-33,35,37,39-44,46,51,54,58-60,67]. Eighty-three
percent of trials (29/35) declared that at least one author
was involved in the development of the system
[15,25-33,36,37,39-41,45-53,55-60,62-68]. In general,
user interfaces were not described in detail. Additional
file 3, Table S3 gives further description of the setting
and method of CCDSS implementation.
The 35 trials included a total of 4,212 practitioners
(median, 132; ranging from 14 to 600, when reported)
caring for 626,382 patients (median, 2,765; ranging from
164 to 400,000, when reported) in 835 clinics (median,
15; ranging from 1 to 142, when reported) across 545
distinct sites (median, 4.5; ranging from 1 to 112, when
reported).
Three trials did not declare a funding source
[31,57,60]. Of those that did, 78% (25/32) were publi-
cally funded [15,25-30,36-38,41-51,54,56,58,
59,61-64,66-68], 9% (3/32) received both private and
public funding [39,40,55,61], and 13% (4/32) were con-
ducted with private funds only [32-35,65].
CCDSS effectiveness
Each system’s impact on the use of diagnostic tests is
summarized in Table 1, and Additional file 4, Table S4
provides a detailed description of test ordering out-
comes. These outcomes were primary in 37% (13/35) of
trials [15,25-27,31,41,50-53,55,58,61-63,66].
Fifty-six percent (18/33) of evaluated trials demon-
strated an impact on the use of diagnostic tests
[15,25-31,41,52,53,55-57,59-64,66,67] Two studies
[65,68] met all eligibility criteria and included diagnostic
process measures but were excluded from the assess-
ment of effectiveness because they did not provide sta-
tistical comparisons of these measures.
Disease monitoring
Systems in 49% (17/35) of trials (median quality score, 7;
ranging from 4 to 10) gave recommendations for moni-
toring active conditions, all focusing on chronic diseases
[25-49]. Their effectiveness for improving all processes
of care and patient outcomes was assessed in our review
on chronic disease management. Here we looked specifi-
cally for their impact on monitoring activity and found
that 35% (6/17) increased appropriate monitoring
[25-31,41].
In the context of diabetes, four of eight trials success-
fully increased timely monitoring of common targets
such as HbA1c, blood lipids, blood pressure, urine albu-
min, and foot and eye health [26-30,41]. One of two sys-
tems that focused primarily on monitoring of
hypertension was effective at increasing the frequency of
appropriate blood pressure measurement [31]. One of
three trials that focused on dyslipidemia improved mon-
itoring of blood lipids [25]. Another three systems gave
suggestions for monitoring of asthma [35,37,39,40],
angina [39,40], chronic obstructive pulmonary disease
(COPD) [37], and one for a combination of renal dis-
ease, obesity, and hypertension [47-49], but all failed to
change testing behavior.
Treatment monitoring
Systems in 23% of trials (8/35) [34,50-57] provided sug-
gestions for laboratory monitoring of drug therapy.
Trials in this area were generally recent and of high
bOutcomes are evaluated for effect as positive (+) or negative (-) for CCDSS, or no effect (0), based on the following hierarchy. An effect is defined as ≥50% of
relevant outcomes showing a statistically significant difference (2p< 0.05):
1. If a single primary outcome is reported, in which all components are applicable, this is the only outcome evaluated.
2. If >1 primary outcome is reported, the ≥50% rule applies and only the primary outcomes are evaluated.
3. If no primary outcomes are reported (or only some of the primary outcome components are relevant) but overall analyses are provided, the overall analyses
are evaluated as primary outcomes. Subgroup analyses are not considered.
4. If no primary outcomes or overall analyses are reported, or only some components of the primary outcome are relevant for the clinical care area, any reported
prespecified outcomes are evaluated.
5. If no clearly pre-specified outcomes are reported, any available outcomes are considered.
6. If statistical comparisons are not reported, ‘effect’ is designated as not evaluated (...).
cGives suggestions for monitoring of disease and treatment and is included in both categories. Outcomes were analyzed separately in each category but overall
analysis of effectiveness (reported in text) was assessed for all diagnostic testing outcomes.
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published since 2005). They targeted a wide range of
medications (described in Additional file 4, Table S4)
and are discussed in detail in our review of CCDSSs for
drug prescribing, which looked for effects on prescribing
behavior and patient outcomes. Focusing on their effec-
tiveness for improving laboratory monitoring, we found
that 63% (5/8) improved practices such as timely moni-
toring for adverse effects of medical therapy
[34,52,53,55-57]. However, two of the trials demonstrat-
ing an impact were older and had low methodologic
scores [56,57].
Diagnosis
Systems in 17% of trials (6/35) [58-64] gave recommen-
dations for ordering tests intended to aid diagnosis
(median quality score, 7.5; ranging from 6 to 9) and 67%
(4/6) were published since 2005 [58-61]. Eighty-three
percent (5/6) successfully improved test ordering beha-
vior [59-64]. Systems suggested tests to investigate sus-
pected dementia in primary practice [60], to detect the
source of fever for children in the emergency room [59],
to increase bone mineral density measurements for diag-
nosing osteoporosis [61], to reduce unnecessary labora-
tory tests for diagnosing urinary tract infections or sore
throats [62,63], to diagnose HIV [58], and to diagnose a
host of conditions, including cancer, thyroid disorders,
anemia, tuberculosis, and others [64].
Other
Finally, five trials did not specify the clinical purpose of
recommended tests [15,65-68], or suggested tests for
several purposes but without data necessary to isolate
the effects on testing for any one purpose. Three of five
focused on reducing ordering rates and were successful
[15,66,67]. Javitt et al. intended to increase test ordering
and measured compliance with suggestions, but did not
evaluate the outcome due to technical problems [65].
Overhage et al. meant to increase ‘corollary orders’
(tests to monitor the effects of other tests or treat-
ments), but did not present statistical comparisons of
their data on diagnostic process outcomes [68].
Costs and practical process-related outcomes
Potentially important factors such as user satisfaction,
adverse events, and impact on cost and workflow were
rarely studied (see Additional file 5, Table S5). Because
most systems also gave recommendations for therapy,
w ew e r eu s u a l l yu n a b l et oi s o l a t et h ee f f e c t so ft e s t -
ordering suggestions on these factors, and here we dis-
cuss systems that gave only testing advice.
Two trials estimated statistically significant reductions
in the cost of care, but estimates were small in one
study [37] and imprecise (large confidence interval) in
the other [28,29]. A third study estimated a relatively
small reduction in annual laboratory costs ($35,000), but
presented no statistical comparisons [66].
Three trials formally evaluated user satisfaction. One
study found mixed satisfaction with a system for moni-
toring of diabetes and postulated that this was due to
technical difficulties [26,27]. Another found that 78% of
users felt CCDSS suggestion for ordering of HIV tests
had an effect on their test-ordering practices, despite
failing to show an effect of the CCDSS in the study [58].
The third study found that, regardless of high satisfac-
tion with the local CPOE system, satisfaction with
reminders about potentially redundant laboratory tests
was lower (3.5 on a scale of 1 to 7) [66].
Only one study formally looked for adverse events
caused by the CCDSS [66]. The system was designed to
reduce potentially redundant clinical laboratory tests by
giving reminders. Researchers assessed the potential for
adverse events by checking for new abnormal test
results for the same test performed after initial cancella-
tion. Fifty-three percent of accepted reminders for a
redundant test were followed by the same type of test
within 72 hours, and 24% were abnormal, although only
4% provided new information and 1% led to changes in
clinical management.
One study made a formal attempt to measure impact
on user workflow and found that use of the CCDSS did
not increase length of clinical encounters [45]. However,
this outcome was not prespecified and the study may
not have had adequate statistical power to detect an
effect.
Discussion
Our systematic review of RCTs of CCDSSs for diagnos-
tic test ordering found that overall testing behavior was
improved in just over one-half of trials. We considered
studies ‘positive’ if they showed a statistically significant
improvement in at least 50% of diagnostic process
outcomes.
While the earliest RCT of a system for this purpose
was published in 1976, most examples have appeared in
the past five years, and evaluation methods have
improved with time. Systems’ diagnostic test ordering
advice was most often intended to increase the ordering
of certain tests in specific situations. Most systems sug-
g e s t e dt e s t st od i a g n o s en e wc o n d i t i o n s ,t om o n i t o r
existing ones, or to monitor recently initiated drug treat-
ments. Trials often demonstrated benefits in the areas of
diagnosis and treatment monitoring, but were seldom
effective for disease monitoring. All four systems that
were explicitly meant to decrease unnecessary testing
were successful [15,62,63,66,67]. CCDSSs may be better
suited for some purposes than for others, but we need
more trials and more detailed reporting of potential
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characteristics, to reliably assess the relationship
between purpose and effectiveness.
Previous reviews have separately synthesized the litera-
ture on ways of improving diagnostic testing practice
and on the effectiveness of CCDSSs [2,12-14,17-19,69].
Our current systematic review combines these areas and
isolates the impact of CCDSS on diagnostic test order-
ing. However, several factors limited our analysis.
Importantly, we chose not to evaluate effects on patient
outcomes because many systems also gave treatment
suggestions that affect these outcomes more directly
than does test ordering advice. Some systems gave
recommendations for testing but their respective studies
did not measure the impact on test ordering practice
and were, therefore, excluded from this review [70-72].
Only 37% of trials assessed impact on test ordering
activity as a primary outcome, and others may not have
had adequate statistical power to detect testing effects.
We did not determine the magnitude of effect in each
study, there being no common metric for this, but sim-
ply considered studies ‘positive’ if they showed a statisti-
cally significant improvement in at least 50% of
diagnostic process outcomes. As a result, some of the
systems considered ineffective by our criteria reported
statistically significant findings, but only for a minority
of secondary or non-prespecified outcomes. Indeed, the
limitations of this ‘vote counting’ [73] are well estab-
lished and include increased risk of underestimating
effect. However, our results remain essentially
unchanged from our 2005 review [19] and are compar-
able to another major review [74], and a recent
‘umbrella’ review of high-quality systematic reviews of
CCDSSs in hospital settings [75].
Vote counting prevented us from assessing publication
bias but we believe that, along with selective outcome
reporting, publication bias is a real issue in this litera-
ture because most systems were tested by their own
developers.
We observed an improvement in trial quality over time,
but this may simply reflect better reporting after standards
such as Consolidated Standards of Reporting Trials (CON-
SORT) were widely adopted. Thirty-one percent of the
authors we attempted to contact did not respond, and this
may have particularly affected the quality of our extraction
from older, less standardised reports.
While the number of RCTs has increased, the majority
of these studies did not investigate or describe poten-
tially important factors, including details of system
design and implementation, costs and effects on user
satisfaction, and workflow. Reporting such information
is difficult under the space constraints of a trial publica-
tion, but supplementary reports may be an effective way
to communicate these important details. One example
comes from Flottorp et al. [62,63] who reported a pro-
cess evaluation exploring the factors that affected the
success of their CCDSS for management of sore throat
and urinary tract infections. Feedback from practices
showed that they were generally satisfied with installing
and using the software, its technical performance, and
with entering data. It also showed where they faced
implementation challenges and which components of
the intervention they used.
Our systematic review uncovered only three studies
evaluating CCDSSs that give advice for the use of diag-
nostic imaging tests [35,61,64]. Effective decision sup-
port for ordering of imaging tests may be particularly
relevant for the delivery of high quality, sustainable,
modern healthcare, given the high cost and rapidly
increasing use of such tests, and emerging concerns
about cancer risk associated with exposure to medical
radiation [11,76,77].
Conclusions
Some CCDSSs improve practitioners’ diagnostic test
ordering behavior, but the determinants of success and
failure remain unclear. CCDSSs may be better suited to
improve testing for some purposes than others, but more
trials and more detailed descriptions of system features
and implementation are needed to evaluate this relation-
ship reliably. Factors of interest to innovators who
develop CCDSSs and decision makers considering local
deployment are under-investigated or under-reported.
To support the efforts of system developers, researchers
should rigorously measure and report adverse effects of
their system and impacts on user workflow and satisfac-
tion, as well as details of their systems’ design (e.g.,u s e r
interface characteristics and integration with other sys-
tems). To inform decision makers, researchers should
report costs of design, development, and implementation.
Additional material
Additional file 1: Study methods scores for trials of diagnostic test
ordering. Methods scores for the included studies.
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